# Acoart SCB SFA: Sirolimus Coated Balloon Catheter in the Treatment of Femoropopliteal Artery Stenosis

> **NCT04982367** · NA · UNKNOWN · sponsor: **Acotec Scientific Co., Ltd** · enrollment: 166 (estimated)

## Conditions studied

- Peripheral Artery Disease

## Interventions

- **DEVICE:** Sirolimus-eluting balloon catheter
- **DEVICE:** Paclitaxel-eluting balloon catheter

## Key facts

- **NCT ID:** NCT04982367
- **Lead sponsor:** Acotec Scientific Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-08
- **Primary completion:** 2024-07
- **Final completion:** 2024-07
- **Target enrollment:** 166 (ESTIMATED)
- **Last updated:** 2023-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04982367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04982367, "Acoart SCB SFA: Sirolimus Coated Balloon Catheter in the Treatment of Femoropopliteal Artery Stenosis". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT04982367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*